Search

You searched for "floater"

1449 results found

Newmedica calls for transparency over glaucoma waiting lists and more collaboration with community optometrists

4 July 2025 | glaucoma, waiting list, news, industry, Newmedica
Ophthalmology provider Newmedica is calling for greater transparency by all providers over glaucoma waiting lists to tackle a ‘postcode lottery’ facing patients. Coinciding with Glaucoma Awareness Week (30 June – 6 July), Newmedica, which provides NHS and private ophthalmology services,...

New President and President-elect of the UK and Éire Glaucoma Society announced

1 May 2022
Glaucoma UK has announced the appointments of the new President and President-elect for its UK and Éire Glaucoma Society (UKEGS).

First online education day for locum optometrists

19 June 2023 | optometry, AOP, locum education event
The AOP’s online locum day will take place on Sunday 25 June, 09:30-15:45.

United Kingdom and Eire Glaucoma Society (UKEGS) Conference: Last chance for Early Bird tickets!

10 July 2024 | UKEGS, events, conference, congress, early bird, glaucoma, glaucoma uk, diary, Nishani Amerasinghe, Anthony King, Andrew Tatham
The United Kingdom and Eire Glaucoma Society (UKEGS) invites you to its annual conference, hosted by Consultant Ophthalmologist Nishani Amerasinghe, on 9 and 10 October 2024 at the National Oceanography Centre in Southampton.

Moorfields: Therapeutics CPD course for optometrists

19 November 2025 -20 November 2025
The Optometry Education Team is pleased to offer a comprehensive CPD course for hospital and community-based optometrists with an interest in the therapeutic management of ocular conditions.

Sutureless, scleral fixated-IOLs

1 April 2020 | | EYE - Cataract, EYE - Refractive
This was a retrospective cohort study of 112 sutureless, scleral-fixated posterior chamber intraocular lens implantations (SSFCIOL) over a four-year time period. Mean follow-up duration was 13.0 ±10.4 months. The primary indication for SSFCIOL was dislocation of IOL due to zonular...
JCRS journal cover image.

Fifteen-year results of phakic artisan IOL for hyperopia correction

4 August 2021 | | EYE - Cataract, EYE - Refractive
This retrospective review of a cohort of 61 eyes from 32 patients offers long-term results for phakic Artisan (Ophtec BV) iris-fixated phakic IOL (IF-pIOL). The mean age at surgery was 41.6 years with a range of 25-59 years. Refractive outcomes...

Artists Unite to showcase experiences of sight loss in new collection

1 June 2022 |
The exhibition will open on 10 June as part of the Wandsworth Arts Fringe in London.

Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity

5 June 2023 |
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...

Papilloedema: an update

1 June 2016 | | EYE - Neuro-ophthalmology
Some readers may have seen a recent report in the national newspapers of the case of a teenage girl with persistent severe headache associated with a fatal brain tumour having been undiagnosed despite many consultations with her medical advisers. It...

Radiation retinopathy

5 June 2020 | | EYE - Vitreo-Retinal, EYE - General
The authors review the current treatment options for this condition. Radiation retinopathy (RR) occurs as a complication after exposure to any type of radiation (external beam, plaque brachytherapy and stereotactic radiosurgery) in the orbital or adnexal region. These include nasopharyngeal...

The Story of Looking: Mark Cousins

5 June 2023 | | EYE - Cataract, EYE - Refractive
Lake, Sweden, as featured in The Story Of Looking. In an interview with Director Mark Cousins about his relationship with sight and storytelling, Peter Cackett discusses Cousins’ recent film, The Story of Looking, and how its production informed, and was...